Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors

LN Klapper, MH Kirschbaum, M Seta… - Advances in cancer …, 1999 - Elsevier
Publisher Summary Carcinoma, cancer of epithelial cells, is a major cause of morbidity and
mortality. Clonal fixation and propagation of oncogenic genetic changes, sporadically …

[图书][B] Pathology and genetics of tumours of the nervous system.

P Kleihues, WK Cavenee - 2000 - cabidigitallibrary.org
This book on the World Health Organization (WHO) classification of tumours of the nervous
system reflects the view of a working group that convened for an editorial and consensus …

Epidermal growth factor receptor family (EGFR, ErbB2–4) in gliomas and meningiomas

U Andersson, D Guo, B Malmer, AT Bergenheim… - Acta …, 2004 - Springer
Overexpression of epidermal growth factor receptor (EGFR, ErbB1) correlates with
enhanced malignant potential of many human tumor types including glioblastoma …

Recurrence/regrowth in grade I meningioma: how to predict?

GTC Carvalho, WC Silva-Martins… - Frontiers in …, 2020 - frontiersin.org
The HLA-G and HLA-E molecules, Ki67, progesterone (PR), estrogen (ER) and androgen
receptors (AR), p53, COX-2, and HER2 were studied to assess whether the biological …

Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2

DS Osorio, J Hu, C Mitchell, JC Allen, J Stanek… - Journal of Neuro …, 2018 - Springer
Introduction Epidermal growth factor receptors EGFR and ErbB2 are overexpressed in
schwannomas and meningiomas. Preclinical and clinical data indicate that lapatinib, an …

C-erbB2/HER2 in Human Gliomas, Medulloblastomas, and Meningiomas: A Minireview

IS Waage, I Vreim, SH Torp - International journal of surgical …, 2013 - journals.sagepub.com
C-erb B2/HER2 serves as an important prognostic and predictive biomarker in various
human tumors, especially in breast cancer, whereas its role in human intracranial tumors is …

Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence

T Csonka, B Murnyák, R Szepesi, J Bencze… - Folia …, 2016 - termedia.pl
Although tumour recurrence is an important and not infrequent event in meningiomas,
predictive immunohistochemical markers have not been identified yet. The aim of this study …

Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study

D Loussouarn, J Brunon, H Avet-Loiseau, M Campone… - Human pathology, 2006 - Elsevier
The aggressiveness of meningiomas is unpredictable. HER2 represents a well-known
prognostic factor in various tumors such as breast carcinomas. This work was designed to …

The role of MAPK signaling pathway in the Her-2-positive meningiomas

Z Wang, W Wang, S Xu, S Wang, Y Tu… - Oncology …, 2016 - spandidos-publications.com
Meningiomas are common types of adult nerve system tumors. Although most cases are
considered benign, due to its high rate of recurrence and easy malignant progression to …

Expression of minichromosome maintenance MCM6 protein in meningiomas is strongly correlated with histologic grade and clinical outcome

G Gauchotte, C Vigouroux, F Rech… - The American journal …, 2012 - journals.lww.com
Abstract The 2007 World Health Organization histologic grading of meningiomas is
associated with recurrence and clinical outcome. However, distinction of grade I from grade …